FDANonrulemakingFDA-2022-D-2061

Who commented on this docket

Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1301d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 1301d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.